Your browser doesn't support javascript.
loading
Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials.
Verstovsek, Srdan; Mesa, Ruben; Gupta, Vikas; Lavie, David; Dubruille, Viviane; Cambier, Nathalie; Platzbecker, Uwe; Hus, Marek; Xicoy, Blanca; Oh, Stephen T; Kiladjian, Jean-Jacques; Vannucchi, Alessandro M; Gerds, Aaron; Egyed, Miklos; Mayer, Jirí; Sacha, Tomasz; Kawashima, Jun; Morris, Marc; Huang, Mei; Harrison, Claire.
Afiliação
  • Verstovsek S; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Mesa R; UT Health San Antonio Cancer Center, San Antonio, TX.
  • Gupta V; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Lavie D; Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Dubruille V; Centre Hospitalier Universitaire de Nantes (CHU de Nantes), Nantes, France.
  • Cambier N; Service d'hématologie, Centre hospitalier régional universitaire de Lille (CHRU Lille), Lille, France.
  • Platzbecker U; Clinic of Hematology, Cellular Therapy, and Hemostaseology, University of Leipzig, Leipzig, Germany.
  • Hus M; Uniwersytet Medyczny w Lublinie, Lublin, Poland.
  • Xicoy B; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain.
  • Oh ST; Division of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Kiladjian JJ; Université de Paris, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, Paris, France.
  • Vannucchi AM; Center of Research and Innovation of Myeloproliferative Neoplasms (CRIMM), Department of Experimental and Clinical Medicine, University of Florence, Careggi University Hospital, Florence, Italy.
  • Gerds A; Cleveland Clinic, Cleveland, OH.
  • Egyed M; Teaching Hospital Mór Kaposi, Kaposvár, Hungary.
  • Mayer J; Department of Internal Medicine, Haematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Sacha T; Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Kawashima J; Uniwersytet Jagiellonski Collegium Medicum, Krakow, Poland.
  • Morris M; Sierra Oncology, San Mateo, CA.
  • Huang M; Sierra Oncology, San Mateo, CA.
  • Harrison C; Sierra Oncology, San Mateo, CA.
Blood Adv ; 7(14): 3582-3591, 2023 07 25.
Article em En | MEDLINE | ID: mdl-37042865
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Mielofibrose Primária / Inibidores de Janus Quinases / Anemia Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Mielofibrose Primária / Inibidores de Janus Quinases / Anemia Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article